0QBO.LSE Coloplast A/S

Healthcare Commercial Services & Supplies London Exchange
- DKK
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
0.02%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Dec 2022.

Is 0QBO.LSE undervalued?

Graham number

The Graham number of Coloplast A/S cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Coloplast A/S fundamental analysis

No fundamental analysis for Coloplast A/S yet.

Coloplast A/S stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of osto…

Full company profile